Reuters logo
BRIEF-Tianjin Lisheng Pharmaceutical sees H1 FY 2017 net profit to down 15 pct to up 15 pct
April 27, 2017 / 1:53 AM / 7 months ago

BRIEF-Tianjin Lisheng Pharmaceutical sees H1 FY 2017 net profit to down 15 pct to up 15 pct

April 26 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd

* Sees H1 FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 58.9 million yuan to 79.7 million yuan

* Says H1 FY 2016 net profit was 69.3 million yuan

* Says that stable main business as main reason for the forecast

Source text in Chinese:goo.gl/Zp8xO9

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below